生物医药CRO服务
Search documents
益诺思11月17日获融资买入402.06万元,融资余额6127.24万元
Xin Lang Cai Jing· 2025-11-18 01:40
Core Insights - Yinosh experienced a decline of 2.28% on November 17, with a trading volume of 41.92 million yuan [1] - The company reported a financing net buy of -770,200 yuan on the same day, indicating a negative sentiment among investors [1] - As of November 17, the total margin balance for Yinosh was 61.27 million yuan, which is 1.42% of its market capitalization, reflecting a low financing level compared to the past year [1] Financial Performance - For the period from January to September 2025, Yinosh achieved a revenue of 571 million yuan, representing a year-on-year decrease of 35.33% [2] - The company reported a net profit attributable to shareholders of -14.79 million yuan, a significant decline of 111.14% compared to the previous year [2] Shareholder and Institutional Holdings - As of September 30, 2025, the number of Yinosh shareholders decreased by 9.97% to 4,849, while the average circulating shares per person increased by 257.28% to 18,703 shares [2] - The company has distributed a total of 45.11 million yuan in dividends since its A-share listing [3] - New institutional shareholders include Huatai-PineBridge Healthcare Mixed Fund and Huaxia Stable Growth Mixed Fund, which are now among the top ten circulating shareholders [3]
益诺思11月11日获融资买入1001.41万元,融资余额6392.16万元
Xin Lang Cai Jing· 2025-11-12 01:40
Core Insights - Yinosh experienced a stock price increase of 10.46% on November 11, with a trading volume of 163 million yuan [1] - The company reported a significant decline in revenue and net profit for the first nine months of 2025, with revenue of 571 million yuan, down 35.33% year-on-year, and a net loss of 14.79 million yuan, a decrease of 111.14% [2] Financing and Trading Activity - On November 11, Yinosh had a financing buy-in amount of 10.01 million yuan and a net financing outflow of 5.66 million yuan, with a total financing balance of 63.92 million yuan, representing 1.41% of its market capitalization [1] - The financing balance is below the 20th percentile of the past year, indicating a low level of financing activity [1] - There were no short sales or repayments on November 11, with the short selling balance at zero, which is at the 90th percentile of the past year, indicating a high level of short selling activity [1] Shareholder and Institutional Holdings - As of September 30, the number of shareholders for Yinosh decreased by 9.97% to 4,849, while the average number of circulating shares per person increased by 257.28% to 18,703 shares [2] - The company has distributed a total of 45.11 million yuan in dividends since its A-share listing [3] - New institutional shareholders include Huatai-PineBridge Healthcare Mixed Fund and Huaxia Stable Growth Mixed Fund, while several funds exited the top ten circulating shareholders list [3]